This study is designed to look at certain blood parameters like biomarkers for predicting the outcome of COVID patients
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/10/028436
- Lead Sponsor
- Dr Amarja Havaldar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with COVID 19 pneumonia admitted in IC
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the trend of biomarkers and itâ??s effect on outcome (ICU mortality)in patients admitted with the diagnosis of COVID pneumonia.Timepoint: ICU mortality or at the end of 4 weeks <br/ ><br>Hospital mortality or at the end of 90 days
- Secondary Outcome Measures
Name Time Method 1.To study the number of ventilator free days <br/ ><br>2. To study the difference in ICU length of stay <br/ ><br> <br/ ><br>Timepoint: ICU mortality or at 4 weeks